Clinical trial
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
NCT00486200 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00486200 |
|---|---|
| Title | A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes |
| Official title | A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Genitalis |
| Intervention type | Drug |
| Interventions | ASP2151, valacyclovir, Placebo |
| Enrollment | 695 |
| Start date | Jun 21, 2007 |
| Primary completion | Aug 12, 2008 |
| Completion | Aug 12, 2008 |
| First posted | Jun 14, 2007 |
| Last update posted | Dec 7, 2017 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: